Evidence map›Paper›PMID 33233586›Full record

ReviewInternational journal of molecular sciences2020

Microbial Upgrading of Acetate into Value-Added Products-Examining Microbial Diversity, Bioenergetic Constraints and Metabolic Engineering Approaches.

Regina Kutscha, Stefan Pflügl

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. COProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Activation-Free Upgrading of Carboxylic Acids to Aldehydes and Alcohols.bioRxiv : the preprint server for biology · 2025
    Article
  6. Metabolic Engineering ofACS synthetic biology · 2025
    Article
  7. Article
  8. Viability and probiotic activity ofFood science and biotechnology · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Perspectives for Using COBioengineering (Basel, Switzerland) · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Regina KutschaInstitute for Chemical, Environmental and Bioscience Engineering, Research Area Biochemical Engineering, Technische Universität Wien, Gumpendorfer Straße 1a, 1060 Vienna, Austria.ORCID 0000-0002-6720-7634
Stefan PflüglInstitute for Chemical, Environmental and Bioscience Engineering, Research Area Biochemical Engineering, Technische Universität Wien, Gumpendorfer Straße 1a, 1060 Vienna, Austria.ORCID 0000-0001-8472-5073
TU Wien · AT

Funding

Österreichische Forschungsförderungsgesellschaft 874503
6 · The paper itself

Abstract

Ecological concerns have recently led to the increasing trend to upgrade carbon contained in waste streams into valuable chemicals. One of these components is acetate. Its microbial upgrading is possible in various species, with

Indexed as

AcetatesAcetoneBiocatalysisBiofuelsCarbonEnergy MetabolismEscherichia coliEscherichia coli ProteinsHumansIndustrial MicrobiologyMetabolic EngineeringMetabolic Networks and PathwaysMevalonic AcidSuccinatesTyrosineWater Pollutants, ChemicalAcetatesAcetoneBiofuelsCarbonEscherichia coli Proteinsitaconic acidMevalonic AcidSuccinatesTyrosineWater Pollutants, Chemicalacetateacetate-derived chemicalsacetate metabolismacetate tolerancebioenergetic constraintsEscherichia colimetabolic engineeringprocess engineering

Identifiers

PMID33233586
PMCPMC7699770
OpenAlexW3105251765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.